206 related articles for article (PubMed ID: 37752032)
1. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Mirshahvalad SA; Eisazadeh R; Shahbazi-Akbari M; Pirich C; Beheshti M
Semin Nucl Med; 2024 Jan; 54(1):171-180. PubMed ID: 37752032
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [
Eisazadeh R; Shahbazi-Akbari M; Mirshahvalad SA; Pirich C; Beheshti M
Semin Nucl Med; 2024 Mar; 54(2):293-301. PubMed ID: 38331629
[TBL] [Abstract][Full Text] [Related]
4. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
5. PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies.
Cohen D; Hazut Krauthammer S; Fahoum I; Kesler M; Even-Sapir E
Eur Radiol; 2023 Sep; 33(9):6502-6512. PubMed ID: 37052659
[TBL] [Abstract][Full Text] [Related]
6. Recent topics of the clinical utility of PET/MRI in oncology and neuroscience.
Nakamoto Y; Kitajima K; Toriihara A; Nakajo M; Hirata K
Ann Nucl Med; 2022 Sep; 36(9):798-803. PubMed ID: 35896912
[TBL] [Abstract][Full Text] [Related]
7. Head-to-Head Comparison of
Exterkate L; Hermsen R; Küsters-Vandevelde HVN; Prette JF; Baas DJH; Somford DM; van Basten JA
Eur Urol Oncol; 2023 Dec; 6(6):574-581. PubMed ID: 37230883
[TBL] [Abstract][Full Text] [Related]
8. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
9. Role of FDG PET/CT in Management of Patients with Prostate Cancer.
Sutherland DEK; Azad AA; Murphy DG; Eapen RS; Kostos L; Hofman MS
Semin Nucl Med; 2024 Jan; 54(1):4-13. PubMed ID: 37400321
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
11. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract][Full Text] [Related]
12. Role of
Piccardo A; Trimboli P; Puntoni M; Foppiani L; Treglia G; Naseri M; Bottoni GL; Massollo M; Sola S; Ferrarazzo G; Bruzzone M; Catrambone U; Arlandini A; Paone G; Ceriani L; Cabria M; Giovanella L
Thyroid; 2019 Apr; 29(4):549-556. PubMed ID: 30864903
[TBL] [Abstract][Full Text] [Related]
13. Review of commonly used prostate specific PET tracers used in prostate cancer imaging in current clinical practice.
Niaz MJ; Sun M; Skafida M; Niaz MO; Ivanidze J; Osborne JR; O'Dwyer E
Clin Imaging; 2021 Nov; 79():278-288. PubMed ID: 34182326
[No Abstract] [Full Text] [Related]
14. Breast PET/MRI Hybrid Imaging and Targeted Tracers.
Romeo V; Helbich TH; Pinker K
J Magn Reson Imaging; 2023 Feb; 57(2):370-386. PubMed ID: 36165348
[TBL] [Abstract][Full Text] [Related]
15. PET/CT With
Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
Curr Radiopharm; 2018; 11(1):4-13. PubMed ID: 29090673
[TBL] [Abstract][Full Text] [Related]
16.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
17. The lung cancers: staging and response, CT,
Owens C; Hindocha S; Lee R; Millard T; Sharma B
Br J Radiol; 2023 Aug; 96(1148):20220339. PubMed ID: 37097296
[TBL] [Abstract][Full Text] [Related]
18.
Malaspina S; De Giorgi U; Kemppainen J; Del Sole A; Paganelli G
Radiol Med; 2018 Dec; 123(12):952-965. PubMed ID: 30116970
[TBL] [Abstract][Full Text] [Related]
19. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 11 C-Choline PET/CT for T Staging and Tumor Volume Delineation in Nasopharyngeal Cancer Patients in Comparison to 18 F-FDG PET/CT.
Li C; Yang Y; Hu F; Xu Y; Wu B; Huang J; Yang K; Lan X
Clin Nucl Med; 2023 Jul; 48(7):563-573. PubMed ID: 37115936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
